Evaluation of the WHO 2010 Grading and AJCC/UICC Staging Systems in Prognostic Behavior of Intestinal Neuroendocrine Tumors

The Evolving Landscape of Neuroendocrine Tumors

(2013) Emily K. Bergsland   SEMINARS IN ONCOLOGY

New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy

(2012) M. Dong et al.   CLINICAL CANCER RESEARCH

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

(2012) Ulrich-Frank Pape et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

(2012) Marianne Pavel et al.   NEUROENDOCRINOLOGY

Standard Imaging Techniques for Neuroendocrine Tumors

(2011) David L. Bushnell et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors

(2011) Deepti Dhall et al.   HUMAN PATHOLOGY

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

(2011) Marianne E Pavel et al.   LANCET

Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation

(2011) Ozgur Mete et al.   MODERN PATHOLOGY

Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period

(2011) Lowell Anthony et al.   PANCREAS

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

(2010) N C Turner et al.   BRITISH JOURNAL OF CANCER

The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids

(2010) Eric Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

(2010) Aaron I. Vinik et al.   PANCREAS

The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors

(2010) J. Philip Boudreaux et al.   PANCREAS

The Pathologic Classification of Neuroendocrine Tumors

(2010) David S. Klimstra et al.   PANCREAS

The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement

(2010) Günter Klöppel et al.   VIRCHOWS ARCHIV

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR

(2009) C. TOUMPANAKIS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients

(2008) Christine S. Landry et al.   AMERICAN JOURNAL OF SURGERY

Small Bowel Cancer in the United States

(2008) Karl Y. Bilimoria et al.   ANNALS OF SURGERY

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms

(2008) S. Grozinsky-Glasberg et al.   ENDOCRINE-RELATED CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation

(2008) Thomas J. Vogl et al.   EUROPEAN JOURNAL OF RADIOLOGY

Indium-111–Pentetreotide Scintigraphy and Somatostatin Receptor Subtype 2 Expression: New Prognostic Factors for Malignant Well-Differentiated Endocrine Tumors

(2008) Amani Asnacios et al.   JOURNAL OF CLINICAL ONCOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY